alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
exv10w1






Exhibit 10.1




Amended and Restated

Non-Employee Director Compensation Summary



1. The following non-employee Board members will receive the following annual retainer:




     (a) The non-executive chairman of the Board will receive a $100,000 annual retainer;



     (b) Each non-employee Board member (other than the non-executive chairman of the Board) will
receive a $50,000 annual retainer;



     (c) The chairman of the Audit Committee will receive an additional $10,000 annual retainer;
and



     (d) Each chairman of each Committee of the Board (other than the chairman of the Audit
Committee) will receive an additional $5,000 annual retainer.


2. The annual retainer amounts set forth above shall be payable quarterly in arrears on the fifth
business day prior to the end of each calendar quarter. For each year, any such Board member may
elect (by giving written notice to the Company on or before the first business day of the
applicable calendar year) to receive such annual retainer in the form of shares of Common Stock of
the Company, payable quarterly in arrears on the fifth business day prior to the end of each
calendar quarter under the Town Sports International Holdings, Inc. 2006 Stock Incentive Plan, as
amended (the “Plan”) (with the value of such shares of Common Stock being the Fair Market
Value (as defined in the Plan) thereof on the fifth business day before the end of each calendar
quarter). Notwithstanding the preceding sentence, any Board member who has so elected to receive
such annual retainer in the form of shares of Common Stock of the Company may revoke such election
for the balance of such calendar year by giving written notice to the Company at any time when such
Board member is otherwise eligible to purchase and sell shares of Common Stock of the Company
pursuant to the Company’s then existing trading policies and procedures with respect to such
purchases and sales. This annual retainer will be pro rated for any partial year.



4. Each existing non-employee Board member will receive an annual award of restricted stock on
the third Wednesday of each calendar year as follows, with each award being fully vested as of the
award date, and will otherwise be subject to the terms of the Plan:




     (a) Chairman of the Board: 2,500 shares



     (b) Other non-employee Board member: 1,667 shares


Additional grants may be made from time to time.



5. Each new non-employee Board member joining the Board will receive an initial award of
1,667 shares of restricted stock, which shares shall be fully vested as of the award date. Each new
non-employee Board member will be eligible in the following year to receive the annual restricted
stock award referred to in Section 4 above.



6. No member of the Board will receive any fees for attending any meetings of the Board or its
committees.



7. Each non-employee Board member and each member of a Board committee will be reimbursed for
any out-of-pocket expenses reasonably incurred by him or her in connection with services provided
in such capacity.




Effective May 25, 2011
· i. F. 

REF ID:A275379 

.:-1.o~r ~7, 

"='Cri::! 1 rrn L~,l.~F'1c:a - -..J- J - J.J' T ('I::..( ,..., ,., - , -'--' - v ' ...J. • - • 

Jaa~-~~;_ 

I 

_._ - .... - ---

( 1 ' _) 

( 2) 

'I 

c.= g , a ·1.ch !~' 1. ~:~ ~'OU 

\.::indC'3) 0 re-::ort cri 'IIlP~ we ~C")ll tne J. -='. '· 1

..rro1 1'J 

n.nd-'.1l11ch ~ t..rnnk Y_r ==1_i.Jl'_:-,c!( cLt.lls - the broadcasting sta~1ons. 

I s!:.oul· bs !."l~i gi2te:Cu.l if =::·. ZulJ:.:, e!: 1 3 J.:_-t 

'.:!ould 3U-.TJlv f1~0"1 tlle1r in.teI'11: l gv1 :~ oce t:1e 

ident1:""1C?Pt1cr.3 o:' ::-n~ cf t,h8J3 ao-0 119...t. LLJki."1owri 

s~:t1c:i.s 

-

r __ r> ....... t+,, QA<:l(~ 01"" 1•11r~ 71-11·11 .::,::.f"lt;.1n -_,o - .J J.. J - v """" ..... - _,. - - - ... ~-- J - ......, '..J ..... '\.,,,; - ' --' rir 0 7"'lr1 ....... .-- • -f'ul 1 -~-or+ 0-1 t 10 -01rrr .... -=-1 '"'.:: .:::...,, "e ,~ r ..J :::'-- - o _.. - - - J.. ..,J _..J u .J--o.J .... - - L.J - - ;::, ...... ...... - .J-- -

°\-TT 'TI"\ 1 0 Y') f _)' 1 'YJ Jrov 11 1 r ' I j 1 1 - r- - - - ' 1') ] 1 C u .... v- - .... !' .... ---\.. ' • ..,,, __ - --- .&.._.:::i_ ..J.._ r... - ::) 

~00., r., ~a-.01'·i ~ ..,.. 111 1 - -11 - ~ ·t .j. .... .j. - ~i-i ..::U .... l""A ..::> !. __ i:J _., i::iu _1_ 1;:;. _ ~ _,,_._..l ,.:;'-"-c.c.~u v--...., _..; __ l,,l_u 

ro-O.}O'l"'JQt1on ..,e T'll- T ")In r> ,,....,..,,...-:! ,,,.., .... , ~ C' - 'I"" _, ..._""'-'-... l J....i. •t - u,_,, ..... -:; v--~-..LC"-" ..:J-.J - .L .... ;::;> - --

~Qi!C~rYIGC of t...."1.3 ll,...1S0"1 E'Y]C• c-::::_•:s 'O':'C Cl:~c+_ 

e1th~r nth ycu or :31n•rov, ii'~ C'_l ·1c1'l:.. ;:::l~fs2: i:i. 

T :isv-= not ~ret "Je'3:i :ibl-= 

_;>01nta JOU r.:ii.3eJ. 1 11-':i:1 ..,,.3 but. re~ort3 before long. 

Fl3.? se g1 ve "1..' fI'l '3ndly gne3tlne::s to -:.'ol·Jre l 

i.inckler/ 

Ssq 

@'pproved for Release by NSA on 07-16-2014 pursuantto E.O. 1352a 

II 
REF ID:A275379 

-- - -·-------

I"1r.cv.Br, 'jg,:pt9.11 :-::;~"33 -'1c J"'::.;+ ... .:1::-i 

rest o~ 1ou.:- o~f1c9.rs. : hO::_J9 ~'01J1 '.1rlr\ ~ Lv5'3 to 

get r~~OU.T U3UD f_ iOl~. I ~~1- y-:. X~C 0~8 c,.&'13 Sl TIC~ 1;' 

ret~~n_ '.;)}d _h9~Et to :Ql<--\,~--i:l-Q.Ce ::11'.;{ -~u~ ~Q~~s~. :: - - J - ... __ ..._t;t C~ - - - --'- ' - ....1 - - I -

ff-- r,,- --""" --
/ 

' 

I 

/ 

I 

I 

I 

I 

Jlr. JQbn v; Connarton ~cutive tu.rector 

REF ID:A62920 

13 April 1955 

!be Creater Bew York Hospital .A.u.oc1at1on 

369 Lexi'rlgton Avenue 

Jtev Yo:t"k, »ev 'fork 

Dear Mr. Connprtoni 

' 1 note with interest rou:r return to "active duty." 'lb& 

.toregoing ia quoted t'rora a verbal order 'b111ff husband who 1a 

ill George Wa.ahington Uniw:rsit;y lfoapltal tallowing a heart 

a~tack. Be bida me r;,ay tbat be YOUld have replied earlier 

in salute to tho- ~c~t except -ror the :tact that he 

,., in ~pe untU Msrch 25; atter a mere one week at the 

or,tice Which \la9 taken up with an af'ticial :i-eport and auch ~ttera be vu atricken. He VQndere 1t yau YOUld. be interested 

1n the enclo.ed. clipp1Jls1 the -.tter related and hi;; attack 

ba.ve no connecticm.. We ha4. bow ot the aw.rd tor some time 

)nit he.d been uked not ~ speak ot it until the new ws :'11tl~d oftic:lal~, 

, 1 ui glad to report that he is prQgre•eing aatist"a.ctoriq ~ the dQctora diet.et~ 6 D')Dth in the hoap1tal and a m:>nth or 

'( ~st •t home. 

1°' W:l.th '.f1l1' awn ueurancea or Urterest 1n your success, I aDr:1 

Inclt 

..;. 

Sincerely your&, 

P.s. )(y- husband -.ya hie bigge&t qtJ.er¥ ot all ta, ·~ &b.oul.d. 

the .tood in hoapite.la be so execrable?" 

@'pp roved for Release by NSA on 06-19-2014 pursuantto E .0. 1352a 

I-·~
[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Page 12212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05371]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Discovery Oil, Ltd., I/O Magic Corporation, 
Maydao Corporation, NX Global, Inc, and SensiVida Medical Technologies, 
Inc.; Order of Suspension of Trading

March 4, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Discovery Oil, Ltd. because it has not filed any periodic reports since 
the period ended September 30, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
I/O Magic Corporation because it has not filed any periodic reports 
since the period ended September 30, 2011.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Maydao Corporation because it has not filed any periodic reports since 
the period ended September 30, 2011.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
NX Global, Inc because it has not filed any periodic reports since the 
period ended October 31, 2011.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
SensiVida Medical Technologies, Inc. because it has not filed any 
periodic reports since the period ended May 31, 2011.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed companies is suspended 
for the period from 9:30 a.m. EST on March 4, 2015, through 11:59 p.m. 
EDT on March 17, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-05371 Filed 3-4-15; 4:15 pm]
 BILLING CODE 8011-01-P
<PAGE>
 
                                                                    EXHIBIT 21.1


                                 Subsidiaries


Internet Profiles Corporation           California

Engage Technologies Limited             United Kingdom
Comments from the Council on Environmental Quality on the Interagency Science Consultation Draft Trimethylben zene Assessment

The IRIS Program is to be commended on the new form at for the toxicological reviews. The document is more accessible, easier to read, and there is gr eater transparency in the presentation of key assumptions. The effective use of figures and tab les are also notable. Overall the assessment for 1,2,4- and 1,3,5-trimeth ylbenzene seems sound and defensible. The charge questions largely addressed the key issues and with some minor changes the materials are suitable for external review. One higher level question – why did EPA determine t hat the third isomer, 1,2,3-trimethylbenzene, should not be included? Please provide an explanat ion in the assessment. Since the toxicity data fro m one isomer (1,2,4-TMB) is used to derive the toxici ty values for another (1,3,5-TMB) it is not clear w hat this couldn’t also be done for the third one. In the preamble, we suggest adding some additional information (i.e., internet addresses) to the secon d paragraph in order to facilitate the reader’s abili ty to locate assessments for the chemicals that are not covered by the IRIS program. We also suggest that you replace “White House offices” with Executive Office of the President offices. In the preface, we recommend some modification to t he program interest section. Consider starting with the second sentence (why the assessment is bei ng developed). We also recommend inserting “some” before Superfund sites. Here, and elsewhe re (e.g., second paragraph of preamble) it would be helpful to explain why 1,2,3-TMB is not included (a s noted above). Finally, are there any other progr ams that might have an interest in this assessment? The executive summary starts with a section on effe cts other than cancer. The title of this section, and in particular the “other than cancer” portion, seem s awkward since it precedes the cancer section. We suggest that you move the cancer section forward ra ther than trying to rename the section. For this assessment cancer is not critical, but in many asse ssments it will be one of the most important sectio ns and it may be helpful to revise the historic IRIS f ormat of presenting that information at the end. Finally, we recommend that the IRIS program conside r modifying the new IRIS assessment format to include a section focused on the critical (or co-cr itical) study. For example, we think that some of the information about the critical study that presented in Appendix A could be moved into the main document and expanded upon. Thanks again for the opportunity to review and comm ent on this assessment. Regards,

Stiven Foster Deputy Associate Director for Chemical Regulations Council on Environmental Quality
[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Page 12213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05370]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of China Infrastructure Investment Corp., Order of 
Suspension of Trading

March 4, 2015.
    It appears to the Securities and Exchange Commission 
(``Commission'') that there is a lack of current and accurate 
information concerning the securities of China Infrastructure 
Investment Corp. (``CIIC'') because, among other things, it: (1) Has 
not filed any periodic reports since the Form 10-Q for the period 
ending September 30, 2011, filed on November 14, 2011; and (2) filed a 
Form 8-K on December 16, 2011, stating that the Chief Financial Officer 
(``CFO'') whose signature appears on Forms 10-K and 10-K/A for the year 
ending June 30, 2011, and on Form 10-Q for the quarter ending September 
30, 2011, had resigned from CIIC on September 21, 2011, and had not 
prepared, reviewed, signed or authorized these filings.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of CIIC 
is suspended for the period from 9:30 a.m. EST on March 4, 2015, 
through 11:59 p.m. EDT on March 17, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-05370 Filed 3-4-15; 4:15 pm]
 BILLING CODE 8011-01-P
EX-10.2 LETTER AGREEMENT






Exhibit 10.2




TIME WARNER ENTERTAINMENT COMPANY, L.P.

One Time Warner Center

North Tower

New York, New York 10019




August 5, 2008




Mr. Robert D. Marcus

Senior Executive Vice President &

Chief Financial Officer

Time Warner Cable Inc.

One Time Warner Center

17th Floor, North Tower

New York, NY 10019




     RE:      Clarification of Employment Agreement


Dear Rob:




          This letter serves to confirm our mutual understanding about how your August 15, 2005
employment agreement will affect your equity awards in connection with the planned separation (the
“Separation”) of Time Warner Cable Inc. (“TWC”) from Time Warner Inc. (“Time Warner”). If you
agree with this description, please sign and return a copy of this letter to TWC. These
clarifications will be a part of your employment agreement effective on August 5, 2008.




     1. Under your employment agreement, the Separation will not have an impact on the vesting or
term of your TWC equity awards, nor will the Separation result in any special treatment of your
awards under the TWC LTIP. Accordingly, the Separation will not accelerate the vesting of any of
your TWC equity awards, nor will the term of those awards be shortened on account of the
Separation.



     2. Upon a termination without cause, unless you are then eligible for retirement, all of your
vested TWC and Time Warner stock options, and not just those that vest as a result of such
termination, will remain exercisable for three years after you cease to be treated as an employee
of the Company (but not beyond the original term of the options). This same treatment applies if
you terminate your employment in connection with a “Material Breach” by the Company of your
employment agreement.



     3. The reference in section 7.5 of your employment agreement to the phrase “left the payroll”
will be understood as “ceased to be treated as an employee.”



 









 





	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/ Marc Lawrence-Apfelbaum
 	 
	 	Marc Lawrence-Apfelbaum, 	 
	 	Executive Vice President,

General Counsel & Secretary 	 
	 



Agreed and Accepted:




ROBERT MARCUS




/s/
Robert D. Marcus      




Date: August 5, 2008
# CE2004078EN.01063101.xml

| 27.3.2004 | EN | Official Journal of the European Union | CE 78/631 |
| --- | --- | --- | --- |

27.3.2004

EN

Official Journal of the European Union

CE 78/631

---

(2004/C 78 E/0667)

WRITTEN QUESTION E-3699/03

by Dana Scallon (PPE-DE) to the Commission

(10 December 2003)

Subject:   Objective 1 areas in Connacht/Ulster (Ireland)

Subject:

My Connacht/Ulster constituency at present comprises 8 Objective 1' counties. After the 2004 European elections, the constituency of Connacht/Ulster will be renamed and enlarged. One county will be added, which, at present, has Objective 1 in transition' status. This county is County Clare, at present in the Munster constituency.

Can the European Commission inform me if the enlarged constituency will then comprise 8 Objective 1 in transition' counties and can you also inform me of the proposed status of County Clare?

Answer given by Mr Barnier on behalf of the Commission

(21 January 2004)

(21 January 2004)

The regions eligible under Objective 1 of the Structural Funds, including the regions in transition, are those that were decided by the Commission on 1 July 1999 (1) in accordance with the procedure foreseen in Article 3 of Council Regulation (EC) no. 1260/1999. This decision is unaffected by subsequent changes in administrative boundaries in the Member States. The eight counties of Cavan, Donegal, Galway, Leitrim, Mayo, Monaghan, Roscommon and Sligo remain eligible for Objective 1 until 31 December 2006 while Clare will remain eligible for Objective 1 in transition.

1

---

(1)  1999/502/CE.

1

---
DJ;-. s •. n..- Wilki ~tt.etut o;:-' lo\&~ti~• 

~· "1081 Yi• tt.l;1. . 

~:ln,e.-tl)Q 'Urd'Y&l"l'tt)" ~, .. .J•nt«Y 

REF rn·:A41.587Afl -~ 

Jl 3 APR 195/J,. 

. ' . ' 

a.1~ '.I!elo~ ~.,,"$ htw a-c~ ~ imitaUoil to 

~ip ca tile Sctatifte AtlYiP'f bl'4. · 

XhltllJI ~h,. .w~ Jrartoll ~ two ~ st tlMt Aptll:f1 ~ · 

®Q.Uo.-in.td Vitb the ~t• ~ our. o~putm10.S, eto.tt Mt . 

~).ma •. 

Ht'. :itoJrtQb ~"· ~ ~ l'N.-t tmt ti. ~1 Aj,lri.l ..tloe 

o'!! the·~. 

W:ttl~ r. FRIEl>lfMJ 

r.~1t1f"~~ 

1tlA 001¢Uie A<tvl.1Ql7 loaT4 

M/B; . Announces acceptance of Board membership by Mr. Ao W. Borton 

to menile:rs. of ·the BS.ASAB. · · · 

IT McDOnaldflStLt 1 USAFf 

Asst to S/ASST/~ 

gpproved for Release bv N.SA on 12-01-2014 pursuantto E.O. 1352d
[Federal Register Volume 80, Number 45 (Monday, March 9, 2015)]
[Notices]
[Page 12489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05415]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Organ Transplantation (ACOT)

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration published a 
notice in the Federal Register, FR 2015-03929 (February 26, 2015), 
announcing the meeting for the Advisory Committee on Organ 
Transplantation (ACOT). This action is to add dial-in information.
    Correction: In the Federal Register, FR 2015-03929 (February 26, 
2015), please make the following addition:

    Participants can also join this meeting via conference call by 
calling the toll-free phone number 888-324-4391 and providing the 
participant pass code 7744447.

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-05415 Filed 3-6-15; 8:45 am]
 BILLING CODE 4165-15-P
Exhibit 13.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of
Trinity Biotech plc (the Company) on Form 20-F for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ronan
OCaoimh, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|                       
|-----------------------
|/s/ RONAN OCAOIMH *   
|Ronan OCaoimh         
|Chief Executive Officer

April 24, 2017



|* | The originally executed copy of this Certification will be maintained at the Companys offices and will be made available for inspection upon request.
|- | ------------------------------------------------------------------------------------------------------------------------------------------------------

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except
to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by Trinity Biotech plc for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
#### Means, Plaintiff in error, vs. The State, Defendant in error.

*September 15*

October *3, 1905.*

*Criminal law and practice: Sodomy: Evidence: Accomplice.*

1. In a criminal prosecution for the offense of sodomy, the evidence,. stated in the opinion, is *held*sufficient to warrant conviction.

2. A conviction of a criminal offense may he sustained on. the uncorroborated testimony of an accomplice.

3. A child seven years old is not capable of a legal consent, and hence cannot be an accomplice in committing the offense of sodomy.

EeeoR to review a judgment of the municipal court of' Milwaukee county: A. 0. Brazee, Judge.

*Affirmed.*

*Henry JE. Bradley,*for the plaintiff in error.

Eor the defendant in error the cause was submitted on the brief of the *Attorney General*and *A. G. Titus*and *Waller D.. Corrigan,*assistant attorneys general. ;

Winslow, J.

The plaintiff in error was convicted of a crime against nature under sec. 4591, Stats. 1898, committed by inducing a boy seven years of age to insert his male organ in the mouth of the plaintiff in error. Upon writ of error he claims that as the boy was incapable of penetration in the sense in which that word is used in rape, and incapable of emission, there was no crime under sec. 4591, but only an indecent assault under sec. 4591a, Stats. 1898.

We are unwilling to soil the pages of our Reports with lengthened discussion of the loathsome subject. There is sufficient authority to sustain a conviction in such a case, and, if there were none, we would feel no hesitancy in placing an authority upon the books. *Reg. v. Allen,*1 Den. C. C. 364; *Kelly v. People,*192 Ill. 119, 61 N. E. 425.

It is said that the boy was an accomplice, and that no con*651viction can "be sustained npon bis uncorroborated evidence. Sncb is not the law in this state. It is in the discretion of the trial court whether to direct an acquittal or not. *Black v. State,*59 Wis. 471, 18 N. W. 457; *Porath v. State,*90 Wis. 527, 63 N. W. 1061. Moreover, an accomplice is one who consents, and a boy of such tender years is not capable of legal consent, and hence is not an accomplice. *Kelly v. People, supra; Mascolo v. Montesanto,*61 Conn. 50, 23 Atl. 714.

*By the Court.*— Judgment affirmed.
, 

;' 

. e· REF ID:A415.4 

COPY .-

~ GENSRAL lWRB J. ~ 

· D!rectoz. ~ Ka.ti~ Securitf' ~ . 

. "' . Waebil2Ston a,, o. c. 

· J>eu- GeDeJLla1 C:USmc 

. ·. l waat 'to tlMmk :rou t~ ~ kSnd letter ot J..-, 20, 

ao4. J011l' eel.ecti= ot uq _. lor J081:1ble ~ to the ~conm'111C.atioD8 P-.nel ot tbe 'Natlcma.\ Secarit7 A4vi9oJ'1 

llclai'fl• I le'Ve 1-4· -.e ·taud11arity with 70\ll' act1ntt both 

t~ .. connection ~li-the t~ Resee.TCh U4 ~-­ ~ ano. 12'1 Bell 'l'el9l»lume :labarawlea · ~, ao s e'WftciAte * ~ ot 10\a" ~ · u the aatloml cSeteue am l ebal1 

be W1!7 hlW1 to ott• IQl81t ae a can4Uate tqr tbe Te~11111uatcationa n---1. . ·"I, .. WSJ \"""· 

,,J 

ln ~ ·tbe :personal. h1'tm7 --~ (l'cmu. J>D 398>, . I am af:1ttt to 1a7 that UDtorttmate1¥ both ccpte• haw been l'U1bec1 

ill· the »J"OCe•• eD4 i would Vt!ll'f· tm1Ch app~te 7010" eezd11Js me 

f4DOtber con wb!.cb z vsu retu:M Vi thou 4e1'Y. 

S~]¥, 

.. 

@'pproved for Release by NSA on 12-01-2014 pursuantto E.O. 1352e